Inventor
SANTELLA JOSEPH B
US26 patents
⚠️ This page may combine multiple inventors who share the name “SANTELLA JOSEPH B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
19 patentsUS7183270B2Feb 27, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO52 citations96
US7601844B2Oct 13, 2009
Piperidinyl derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO19 citations91
US10294229B2May 21, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO9 citations84
US9540333B2Jan 10, 2017
Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα
BRISTOL MYERS SQUIBB CO11 citations84
US7338947B2Mar 4, 2008
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO6 citations74
US10202390B2Feb 12, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO3 citations71
US9657009B2May 23, 2017
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO4 citations71
US9546153B2Jan 17, 2017
Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO5 citations71
US9169252B2Oct 27, 2015
Heteroaryl substituted nicotinamide compounds
BRISTOL MYERS SQUIBB CO5 citations71
US8633226B2Jan 21, 2014
Piperidinyl derivative as a modulator of chemokine receptor activity
BRISTOL MYERS SQUIBB CO3 citations62
US7985861B2Jul 26, 2011
Piperidinyl derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO3 citations61
US10479793B2Nov 19, 2019
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO1 citations59
US11981680B2May 14, 2024
Substituted thienopyrroles as PAD4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US10544133B2Jan 28, 2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations52
US7291744B2Nov 6, 2007
N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO2 citations52
US6992091B2Jan 31, 2006
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US10023562B2Jul 17, 2018
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations51
US12570659B2Mar 10, 2026
Bicyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US10618903B2Apr 14, 2020
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO0 citations39